Lirum Therapeutics (Lirum Therapeutics) Total Liabilities : $2.18 Mil (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Lirum Therapeutics Total Liabilities?

Lirum Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 was $2.18 Mil.

Lirum Therapeutics's quarterly Total Liabilities declined from Dec. 2022 ($2.33 Mil) to Sep. 2023 ($1.99 Mil) but then increased from Sep. 2023 ($1.99 Mil) to Dec. 2023 ($2.18 Mil).

Lirum Therapeutics's annual Total Liabilities increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($2.33 Mil) but then declined from Dec. 2022 ($2.33 Mil) to Dec. 2023 ($2.18 Mil).

Lirum Therapeutics Total Liabilities Historical Data

The historical data trend for Lirum Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lirum Therapeutics Total Liabilities Chart

Lirum Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Total Liabilities

2.33

2.18

Lirum Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Sep23	Dec23
Total Liabilities	-	-	2.33	1.99	2.18

Lirum Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lirum Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.18	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.18

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	4.569	-	2.39
	=	2.18

Lirum Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.18	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.18

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	4.569	-	2.39
	=	2.18

Lirum Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Lirum Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lirum Therapeutics (Lirum Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lirum Therapeutics Inc (NAS:LRTX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

590 Madison Avenue, 21st Floor, New York, NY, USA, 10022

Website

https://www.lirumtx.com

Lirum Therapeutics Inc is clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development, and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways, and commercial opportunities. Its product candidate, LX-101, formerly 765IGF-MTX, is a novel, clinical-stage, "next generation," precision-engineered targeted therapy directed to the IGF-1R.

Lirum Therapeutics (Lirum Therapeutics) Headlines

No Headlines